Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 24;80(2):271-279.
doi: 10.1093/cid/ciae538.

Tuberculosis and Increased Incidence of Cardiovascular Disease: Cohort Study Using United States and United Kingdom Health Records

Affiliations

Tuberculosis and Increased Incidence of Cardiovascular Disease: Cohort Study Using United States and United Kingdom Health Records

Julia A Critchley et al. Clin Infect Dis. .

Abstract

Background: Limited evidence suggests elevated risks of cardiovascular disease (CVD) among people diagnosed with tuberculosis (TB) disease, though studies have not adjusted for preexisting CVD risk. We carried out a cohort study using 2 separate datasets, estimating CVD incidence in people with TB versus those without.

Methods: Using data from the United States (Veterans Health Administration) and the United Kingdom (Clinical Practice Research Datalink) for 2000-2020, we matched adults with incident TB disease and no CVD history 2 years before TB diagnosis (US, n = 2121; UK, n = 15 820) with up to 10 people without TB on the basis of age, sex, race/ethnicity and healthcare practice. Participants were followed beginning 2 years before TB diagnosis and for 2 years subsequently. The acute period was defined as 3 months before/after TB diagnosis. TB, CVD, and covariates were identified from electronic routinely collected data (primary and secondary care; mortality). Poisson models estimated incident rate ratios for CVD events in people with TB compared to those without.

Results: CVD incidence was consistently higher in people with TB, including during the baseline period (pre-TB) and particularly in the acute period: incident rate ratios were US, 3.5 (95% confidence interval, 2.7-4.4), and UK, 2.7 (2.2-3.3). Rate ratios remained high after adjusting for differences in preexisting CVD risk: US, 3.2 (2.2-4.4); UK, 1.6 (1.2-2.1).

Conclusions: Increased CVD incidence was observed in people with TB versus those without, especially within months of TB diagnosis, persistent after adjustment for differences in preexisting risk. Enhancing CVD screening and risk management may improve long-term outcomes in people with TB.

Keywords: cardiovascular diseases; cohort study; electronic health records; post-TB; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. L. S. P. declares that there is no duality of interest associated with this manuscript. With regard to potential conflicts of interest, L. S. P. has served on Scientific Advisory Boards for Janssen, and has or had research support from Merck, Pfizer, Eli Lilly, Novo Nordisk, Sanofi, PeriodBio, Roche, Abbvie, Vascular Pharmaceuticals, Janssen, Glaxo SmithKline, and the Cystic Fibrosis Foundation. L. S. P. is also a cofounder and Officer and Board member and stockholder for a company, Diasyst, Inc., which markets software aimed to help improve diabetes management. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Graphical Abstract
Graphical Abstract
This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/tuberculosis-and-increased-incidence-of-cardiovascular-disease-cohort-study-using-us-and-uk-health-records?utm_campaign=tidbitlinkshare&utm_source=ITP
Figure 1.
Figure 1.
A, B, 30-day incidence rates for cardiovascular events, 2 years either side of tuberculosis diagnosis. The overall incidence rate ratio (IRR) for each period is statistically significant for US people in the preacute, acute and postacute periods and for UK people, for all periods (Table 2). Abbreviation: TB, tuberculosis.

References

    1. Fukunaga R, Glaziou P, Harris JB, Date A, Floyd K, Kasaeva T. Epidemiology of tuberculosis and progress toward meeting global targets—Worldwide, 2019. MMWR Morb Mortal Wkly Rep 2021; 70:427–30. - PMC - PubMed
    1. World Health Organization 2022 . Global Tuberculosis Report 2022. Available at: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globa.... Accessed 28 July 2024.
    1. Reid M, Agbassi YJP, Arinaminpathy N, et al. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on tuberculosis. Lancet 2023; 402:1473–98. - PubMed
    1. Jarde A, Romano E, Afaq S, et al. Prevalence and risks of tuberculosis multimorbidity in low-income and middle-income countries: a meta-review. BMJ Open 2022; 12:e060906. - PMC - PubMed
    1. Dodd PJ, Yuen CM, Jayasooriya SM, van der Zalm MM, Seddon JA. Quantifying the global number of tuberculosis survivors: a modelling study. Lancet Infect Dis 2021; 21:984–92. - PubMed

Publication types